Hosein Nouri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hosein Nouri has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Seyed-Hossein Abtahi
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran
14 shared publications Masoud Etemadifar
Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society
8 shared publicationsMehri Salari
Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 shared publicationsSahba Fekri
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 shared publicationsSeyed-Hossein Abtahi
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
6 shared publicationsAmir Parsa Abhari
Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan Multiple Sclerosis Center, Isfahan Multiple Sclerosis Society
5 shared publications
Latest Publications
- Open Access
- 13 July 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-8
Lamina Cribrosa Changes Following Pars Plana Vitrectomy and Silicone Oil Injection for Rhegmatogenous Retinal Detachment: A Contralateral Eye Study
Purpose: To assess changes in lamina cribrosa (LC) characteristics in eyes with silicone oil (SO) due to rhegmatogenous retinal detachment (RRD).Methods: This cross-sectional contralateral eye study was conducted on 49 patients with unilateral RRD who underwent pars plana vitrectomy and SO injection followed by SO removal. The contralateral eyes served as controls. The thickness and depth of LC in both eyes of the participants were evaluated using the enhanced depth imaging technique via optical coherence tomography.Results: The average age of the participants was 57.6 ± 10.5 years, and the mean duration of postoperative SO retention was 6.4 ± 1.7 months. The mean depth of LC was 347.6 ± 64.3 μm in eyes with SO tamponade and 329.6 ± 76.7 μm in healthy eyes (P = 0.232). On the other hand, the LC in eyes with SO tamponade was significantly thinner compared to that in healthy eyes (270.1 ± 45.1 μm vs 303.2 ± 48.6 μm; P < 0.0001). In addition, subgroup analysis revealed that similar findings were obtained after excluding patients who had received antiglaucoma medications to manage increased intraocular pressure (IOP).Conclusion: This study showed that eyes with SO injection exhibit a significantly thinner LCcompared to healthy eyes, with no difference in the depth of the LC between the two groups.
- 13 July 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-8
Open AccessLamina Cribrosa Changes Following Pars Plana Vitrectomy and Silicone Oil Injection for Rhegmatogenous Retinal Detachment: A Contralateral Eye Study
Purpose: To assess changes in lamina cribrosa (LC) characteristics in eyes with silicone oil (SO) due to rhegmatogenous retinal detachment (RRD).Methods: This cross-sectional contralateral eye study was conducted on 49 patients with unilateral RRD who underwent pars plana vitrectomy and SO injection followed by SO removal. The contralateral eyes served as controls. The thickness and depth of LC in both eyes of the participants were evaluated using the enhanced depth imaging technique via optical coherence tomography.Results: The average age of the participants was 57.6 ± 10.5 years, and the mean duration of postoperative SO retention was 6.4 ± 1.7 months. The mean depth of LC was 347.6 ± 64.3 μm in eyes with SO tamponade and 329.6 ± 76.7 μm in healthy eyes (P = 0.232). On the other hand, the LC in eyes with SO tamponade was significantly thinner compared to that in healthy eyes (270.1 ± 45.1 μm vs 303.2 ± 48.6 μm; P < 0.0001). In addition, subgroup analysis revealed that similar findings were obtained after excluding patients who had received antiglaucoma medications to manage increased intraocular pressure (IOP).Conclusion: This study showed that eyes with SO injection exhibit a significantly thinner LCcompared to healthy eyes, with no difference in the depth of the LC between the two groups.
- Open Access
- 19 June 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-4
Probe-assisted ILM-Rhexis: A Novel Peeling Technique
This study describes a novel technique for removing the internal limiting membrane (ILM) using a 25-G vitrectomy probe during the epiretinal membrane (ERM)/ILM double peeling procedure. After standard 3-port 25-gauge pars plana vitrectomy, ERM is removed using membrane forceps and appropriate staining. An incidental ILM flap may occur while washing out the ILM-specific dye with the vitrectomy probe. To prevent this, we suggest not withdrawing the vitrectomy probe, but instead applying proximal and tangential aspiration force over the ILM flap, which may be extended and peeled off by gentle probe maneuvers along the retinal surface. The technique is described in three cases, with details, and shown in a video. This approach has several advantages. It may reduce the number of entries into the posterior segment during pars plana vitrectomy, preventing inadvertent retinal breaks. Furthermore, in cases with fragile ILMs that are hard to elongate with forceps, the active aspiration force of the vitrectomy probe might rapidly extend and form large flaps. We suggest applying this technique in scenarios involving ERM/ILM double peeling and double staining, where an incidental ILM flap is found after washing out the ILM-specific dye.
- 19 June 2026
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 21, 1-4
Open AccessProbe-assisted ILM-Rhexis: A Novel Peeling Technique
This study describes a novel technique for removing the internal limiting membrane (ILM) using a 25-G vitrectomy probe during the epiretinal membrane (ERM)/ILM double peeling procedure. After standard 3-port 25-gauge pars plana vitrectomy, ERM is removed using membrane forceps and appropriate staining. An incidental ILM flap may occur while washing out the ILM-specific dye with the vitrectomy probe. To prevent this, we suggest not withdrawing the vitrectomy probe, but instead applying proximal and tangential aspiration force over the ILM flap, which may be extended and peeled off by gentle probe maneuvers along the retinal surface. The technique is described in three cases, with details, and shown in a video. This approach has several advantages. It may reduce the number of entries into the posterior segment during pars plana vitrectomy, preventing inadvertent retinal breaks. Furthermore, in cases with fragile ILMs that are hard to elongate with forceps, the active aspiration force of the vitrectomy probe might rapidly extend and form large flaps. We suggest applying this technique in scenarios involving ERM/ILM double peeling and double staining, where an incidental ILM flap is found after washing out the ILM-specific dye.
- Open Access
- 5 March 2025
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 15 (1) , 1-6
Scleritis in Iran
Purpose: To present the demographic and clinical presentations of anterior scleritis among Iranian patients. Methods: This retrospective case-series at a tertiary center in Iran, identified and analyzed anterior scleritis cases admitted from 2008 to 2018. Extracted data included demographics, clinical features, background systemic diseases, utilized therapies, and follow-up data on visual outcomes, ocular complications, and recurrence rate. Patients with incomplete records were excluded from the analysis. Results: Sixty-five patients (83 eyes) with anterior scleritis were included, with a female predilection (77%) and a mean age (± SD; range) of 44.8 (± 14.6; 11–81). Diffuse and necrotizing scleritis were the most and least common subtypes, respectively. Bilateral involvement (28% at baseline, 44.6% eventually) and concurrent keratitis (10.7%) or uveitis (16.9%) were documented in some cases. Most cases were idiopathic (61.5%). Scleritis was the initial manifestation of autoimmune diseases in six patients. In addition to oral and/or intravenous corticosteroid therapy, most of our patients (70.7%) were treated with immunosuppressive regimens. No inter-subtype difference was noted in recurrence rate and time to treatment cessation. Necrotizing subtype was associated with worse visual outcomes and more frequent ocular complications. Conclusion: Despite limitations in data collection and follow-up, our findings contribute valuable insights into the clinical characteristics and management of scleritis in a group of Iranian patients for the first time.
- 5 March 2025
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 15 (1) , 1-6
Open AccessScleritis in Iran
Purpose: To present the demographic and clinical presentations of anterior scleritis among Iranian patients. Methods: This retrospective case-series at a tertiary center in Iran, identified and analyzed anterior scleritis cases admitted from 2008 to 2018. Extracted data included demographics, clinical features, background systemic diseases, utilized therapies, and follow-up data on visual outcomes, ocular complications, and recurrence rate. Patients with incomplete records were excluded from the analysis. Results: Sixty-five patients (83 eyes) with anterior scleritis were included, with a female predilection (77%) and a mean age (± SD; range) of 44.8 (± 14.6; 11–81). Diffuse and necrotizing scleritis were the most and least common subtypes, respectively. Bilateral involvement (28% at baseline, 44.6% eventually) and concurrent keratitis (10.7%) or uveitis (16.9%) were documented in some cases. Most cases were idiopathic (61.5%). Scleritis was the initial manifestation of autoimmune diseases in six patients. In addition to oral and/or intravenous corticosteroid therapy, most of our patients (70.7%) were treated with immunosuppressive regimens. No inter-subtype difference was noted in recurrence rate and time to treatment cessation. Necrotizing subtype was associated with worse visual outcomes and more frequent ocular complications. Conclusion: Despite limitations in data collection and follow-up, our findings contribute valuable insights into the clinical characteristics and management of scleritis in a group of Iranian patients for the first time.
- 4 October 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2568-2571
Autoimmune Retinopathy Following COVID-19: A Case Report
PurposeTo present a presumed case of non-paraneoplastic autoimmune retinopathy (nPAIR) following COVID-19 in a healthy woman.MethodsA single case was evaluated and followed for 32 months.ResultsA healthy 32-year-old woman presented with photopsia and paracentral scotoma (OU) after a recent COVID-19 infection. Past medical history and family history were unremarkable. Her visual acuity was normal (OU). Retinal atrophy, mild disc pallor, and foveal reflex attenuation were observed (OU). Optical coherence tomography (OCT) scans showed outer nuclear layer thinning and ellipsoid zone disruption (OU). The visual field test showed blind spot enlargement and arcuate scotomas (OU). Uveitis workup and underlying malignancy investigations were negative. A diagnosis of nPAIR was presumed. At the time, she refused therapy, and 20 months later, her visual acuity was stable, but there were progressive retinal atrophic changes and visual field constriction. After initiation of glucocorticoids and immunosuppressive therapy, flashing lights completely disappeared, her visual field was stabilized without progression, and OCT scans showed partial recovery of ellipsoid zone.ConclusionSARS-CoV-2 infection may be a trigger for nPAIR in susceptible individuals, but further research is needed to determine this association.
- 4 October 2024
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2568-2571
Autoimmune Retinopathy Following COVID-19: A Case Report
PurposeTo present a presumed case of non-paraneoplastic autoimmune retinopathy (nPAIR) following COVID-19 in a healthy woman.MethodsA single case was evaluated and followed for 32 months.ResultsA healthy 32-year-old woman presented with photopsia and paracentral scotoma (OU) after a recent COVID-19 infection. Past medical history and family history were unremarkable. Her visual acuity was normal (OU). Retinal atrophy, mild disc pallor, and foveal reflex attenuation were observed (OU). Optical coherence tomography (OCT) scans showed outer nuclear layer thinning and ellipsoid zone disruption (OU). The visual field test showed blind spot enlargement and arcuate scotomas (OU). Uveitis workup and underlying malignancy investigations were negative. A diagnosis of nPAIR was presumed. At the time, she refused therapy, and 20 months later, her visual acuity was stable, but there were progressive retinal atrophic changes and visual field constriction. After initiation of glucocorticoids and immunosuppressive therapy, flashing lights completely disappeared, her visual field was stabilized without progression, and OCT scans showed partial recovery of ellipsoid zone.ConclusionSARS-CoV-2 infection may be a trigger for nPAIR in susceptible individuals, but further research is needed to determine this association.
- 20 February 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 44 (1) , 1-9
The effect of combination therapy with intravitreal bevacizumab and topical timolol–dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial
Background The mainstay of treatment in diabetic macular edema (DME) is intravitreal administration of anti-vascular endothelial growth factors (anti-VEGFs). Aqueous depressants may enhance the effects of anti-VEGF agents by prolonging their clearance via aqueous outflow. Purpose To compare the anatomical and functional outcomes of treatment with intravitreal bevacizumab (IVB) and topical timolol–dorzolamide versus IVB alone. Method In this randomized placebo-controlled clinical trial, patients with center-involving DME (ci-DME) and best corrected visual acuity (BCVA) of 20/30 or less were enrolled and randomly allocated to two treatment arms. One group received three monthly IVB injections and timolol–dorzolamide eye drops twice a day (IVB + TD group); the other group received three monthly IVB injections and artificial tear drops as placebo (IVB group). Patients underwent ophthalmic evaluations and macular optical coherence tomography scans at baseline and 1 month after the third injection. Result Forty-six eyes from 46 patients with ci-DME were recruited. There was no intergroup difference regarding age, gender distribution, diabetic retinopathy stage, glycemic indices, BCVA, central macular thickness (CMT), or intraocular pressure at baseline. BCVA was significantly improved in the IVB + TD group (0.46 ± 0.18 to 0.36 ± 0.18 logarithm of the minimum angle of resolution [logMAR], p = 0.002), in contrast to IVB group (0.40 ± 0.17 to 0.35 ± 0.22 logMAR, p = 0.113). Similarly, the IVB + TD group showed a significant reduction in CMT (p < 0.001), unlike the IVB group (p = 0.086); and the CMT change in the former was greater than in the latter (− 0.57 ± 57.67 vs. − 25.52 ± 68.02 μm, p = 0.033). Conclusion Our findings support the short-term effectiveness of topical timolol–dorzolamide as adjunctive therapy to IVB injections in managing center-involving DME in terms of anatomical and visual outcomes. Trial registration: Clinicaltrials.gov NCT05083689 (October 19, 2021).
- 20 February 2024
- Published by Springer Nature in International Ophthalmology
- Vol. 44 (1) , 1-9
The effect of combination therapy with intravitreal bevacizumab and topical timolol–dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial
Background The mainstay of treatment in diabetic macular edema (DME) is intravitreal administration of anti-vascular endothelial growth factors (anti-VEGFs). Aqueous depressants may enhance the effects of anti-VEGF agents by prolonging their clearance via aqueous outflow. Purpose To compare the anatomical and functional outcomes of treatment with intravitreal bevacizumab (IVB) and topical timolol–dorzolamide versus IVB alone. Method In this randomized placebo-controlled clinical trial, patients with center-involving DME (ci-DME) and best corrected visual acuity (BCVA) of 20/30 or less were enrolled and randomly allocated to two treatment arms. One group received three monthly IVB injections and timolol–dorzolamide eye drops twice a day (IVB + TD group); the other group received three monthly IVB injections and artificial tear drops as placebo (IVB group). Patients underwent ophthalmic evaluations and macular optical coherence tomography scans at baseline and 1 month after the third injection. Result Forty-six eyes from 46 patients with ci-DME were recruited. There was no intergroup difference regarding age, gender distribution, diabetic retinopathy stage, glycemic indices, BCVA, central macular thickness (CMT), or intraocular pressure at baseline. BCVA was significantly improved in the IVB + TD group (0.46 ± 0.18 to 0.36 ± 0.18 logarithm of the minimum angle of resolution [logMAR], p = 0.002), in contrast to IVB group (0.40 ± 0.17 to 0.35 ± 0.22 logMAR, p = 0.113). Similarly, the IVB + TD group showed a significant reduction in CMT (p < 0.001), unlike the IVB group (p = 0.086); and the CMT change in the former was greater than in the latter (− 0.57 ± 57.67 vs. − 25.52 ± 68.02 μm, p = 0.033). Conclusion Our findings support the short-term effectiveness of topical timolol–dorzolamide as adjunctive therapy to IVB injections in managing center-involving DME in terms of anatomical and visual outcomes. Trial registration: Clinicaltrials.gov NCT05083689 (October 19, 2021).
- Top Cited PapersOpen Access
- 2 January 2024
- Published by Wiley in Journal of Ophthalmology
- Vol. 2024, 1-28
Corneal Epithelial Thickness Mapping: A Major Review
The corneal epithelium (CE) is the outermost layer of the cornea with constant turnover, relative stability, remarkable plasticity, and compensatory properties to mask alterations in the underlying stroma. The advent of quantitative imaging modalities capable of producing epithelial thickness mapping (ETM) has made it possible to characterize better the different patterns of epithelial remodeling. In this comprehensive synthesis, we reviewed all available data on ETM with different methods, including very high-frequency ultrasound (VHF-US) and spectral-domain optical coherence tomography (SD-OCT) in normal individuals, corneal or systemic diseases, and corneal surgical scenarios. We excluded OCT studies that manually measured the corneal epithelial thickness (CET) (e.g., by digital calipers) or the CE (e.g., by confocal scanning or handheld pachymeters). A comparison of different CET measuring technologies and devices capable of producing thickness maps is provided. Normative data on CET and the possible effects of gender, aging, diurnal changes, refraction, and intraocular pressure are discussed. We also reviewed ETM data in several corneal disorders, including keratoconus, corneal dystrophies, recurrent epithelial erosion, herpes keratitis, keratoplasty, bullous keratopathy, carcinoma in situ, pterygium, and limbal stem cell deficiency. The available data on the potential role of ETM in indicating refractive surgeries, planning the procedure, and assessing postoperative changes are reviewed. Alterations in ETM in systemic and ocular conditions such as eyelid abnormalities and dry eye disease and the effects of contact lenses, topical medications, and cataract surgery on the ETM profile are discussed.
- 2 January 2024
- Published by Wiley in Journal of Ophthalmology
- Vol. 2024, 1-28
Top Cited PapersOpen AccessCorneal Epithelial Thickness Mapping: A Major Review
The corneal epithelium (CE) is the outermost layer of the cornea with constant turnover, relative stability, remarkable plasticity, and compensatory properties to mask alterations in the underlying stroma. The advent of quantitative imaging modalities capable of producing epithelial thickness mapping (ETM) has made it possible to characterize better the different patterns of epithelial remodeling. In this comprehensive synthesis, we reviewed all available data on ETM with different methods, including very high-frequency ultrasound (VHF-US) and spectral-domain optical coherence tomography (SD-OCT) in normal individuals, corneal or systemic diseases, and corneal surgical scenarios. We excluded OCT studies that manually measured the corneal epithelial thickness (CET) (e.g., by digital calipers) or the CE (e.g., by confocal scanning or handheld pachymeters). A comparison of different CET measuring technologies and devices capable of producing thickness maps is provided. Normative data on CET and the possible effects of gender, aging, diurnal changes, refraction, and intraocular pressure are discussed. We also reviewed ETM data in several corneal disorders, including keratoconus, corneal dystrophies, recurrent epithelial erosion, herpes keratitis, keratoplasty, bullous keratopathy, carcinoma in situ, pterygium, and limbal stem cell deficiency. The available data on the potential role of ETM in indicating refractive surgeries, planning the procedure, and assessing postoperative changes are reviewed. Alterations in ETM in systemic and ocular conditions such as eyelid abnormalities and dry eye disease and the effects of contact lenses, topical medications, and cataract surgery on the ETM profile are discussed.
- Open Access
- 30 November 2023
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 18 (4) , 452-457
The First Reported Case of Ocular Syphilis in an Iranian Patient
Purpose: To report the first case of ocular syphilis in an Iranian patient and discuss its diagnostic challenges. Case Report: A man in his mid-70s presented with progressive bilateral visual and auditory decline. He had previously lived in a Southeast Asian country for 10 years. Prior steroid therapies entailed no inflammation subsidence. His visual acuity at presentation was light perception OU. Funduscopic findings included severe vitritis, severe optic atrophy, diffuse retinal vascular occlusion, and diffuse retinal atrophy OU. Angiography demonstrated diffuse areas of retinal and choriocapillaris atrophy with no active choroiditis. Scaly cutaneous lesions were noted on his palms and soles – atypical findings of secondary syphilis. Serum analysis revealed an underlying syphilis infection. The cerebrospinal fluid sample was reactive to anti-syphilis antibodies, securing a neurosyphilis diagnosis. Two weeks of antibiotic therapy resulted in cutaneous lesions resolution and relative visual improvement despite extensive baseline retinal atrophic damage. Conclusion: Ocular syphilis can mimic numerous ocular inflammatory scenarios. In cases of ocular inflammation that is unresponsive to steroids, reconsidering alternative diagnoses, especially infections with the highest clinical relevance, is necessary. We stress the importance of acquiring patients’ sexual history, regardless of cultural barriers and the rarity of the entity in some regions.
- 30 November 2023
- Published by Knowledge E DMCC in Journal of Ophthalmic and Vision Research
- Vol. 18 (4) , 452-457
Open AccessThe First Reported Case of Ocular Syphilis in an Iranian Patient
Purpose: To report the first case of ocular syphilis in an Iranian patient and discuss its diagnostic challenges. Case Report: A man in his mid-70s presented with progressive bilateral visual and auditory decline. He had previously lived in a Southeast Asian country for 10 years. Prior steroid therapies entailed no inflammation subsidence. His visual acuity at presentation was light perception OU. Funduscopic findings included severe vitritis, severe optic atrophy, diffuse retinal vascular occlusion, and diffuse retinal atrophy OU. Angiography demonstrated diffuse areas of retinal and choriocapillaris atrophy with no active choroiditis. Scaly cutaneous lesions were noted on his palms and soles – atypical findings of secondary syphilis. Serum analysis revealed an underlying syphilis infection. The cerebrospinal fluid sample was reactive to anti-syphilis antibodies, securing a neurosyphilis diagnosis. Two weeks of antibiotic therapy resulted in cutaneous lesions resolution and relative visual improvement despite extensive baseline retinal atrophic damage. Conclusion: Ocular syphilis can mimic numerous ocular inflammatory scenarios. In cases of ocular inflammation that is unresponsive to steroids, reconsidering alternative diagnoses, especially infections with the highest clinical relevance, is necessary. We stress the importance of acquiring patients’ sexual history, regardless of cultural barriers and the rarity of the entity in some regions.
- 10 November 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (1) , 104021
Retinal arterial occlusion and patent foramen ovale: A case study-based review
- 10 November 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 47 (1) , 104021
Retinal arterial occlusion and patent foramen ovale: A case study-based review
- Open Access
- 26 September 2023
- Published by Springer Nature in Research Square
Probe-Assisted ILM-Rhexis: A Novel Peeling Technique
Background and Objective: To describe a novel surgical technique of removing internal limiting membrane (ILM) using a 25 G vitrectomy probe amid epiretinal membrane (ERM)/ILM double peeling operation. Materials and Methods After standard 3-port 25-gauge pars plana vitrectomy, ERM is removed using membrane forceps and appropriate staining. When washing out the ILM-specific dye by the vitrectomy probe an incidental ILM flap may be noticed. We suggest not drawing out the vitrectomy probe but instead applying proximal and tangential aspiration force over the ILM flap, which may be extended and peeled off by gentle probe maneuvers along the retinal surface. Results The technique is described in three opertaed cases. Details of probe maneuvers are displayed in a video. Conclusion We suggest applying this technique amid surgical scenarios involving ERM/ILM double peeling and double staining where an incidental ILM flap is found after washing out of the ILM-specific dye. Advantages over using conventional forcerps include the reduced number of entries into the posterior segment, lower risk of inadvertent retinal breaks, better safety profile, and easier-to-perform elongation of ILM flaps.
- 26 September 2023
- Published by Springer Nature in Research Square
Open AccessProbe-Assisted ILM-Rhexis: A Novel Peeling Technique
Background and Objective: To describe a novel surgical technique of removing internal limiting membrane (ILM) using a 25 G vitrectomy probe amid epiretinal membrane (ERM)/ILM double peeling operation. Materials and Methods After standard 3-port 25-gauge pars plana vitrectomy, ERM is removed using membrane forceps and appropriate staining. When washing out the ILM-specific dye by the vitrectomy probe an incidental ILM flap may be noticed. We suggest not drawing out the vitrectomy probe but instead applying proximal and tangential aspiration force over the ILM flap, which may be extended and peeled off by gentle probe maneuvers along the retinal surface. Results The technique is described in three opertaed cases. Details of probe maneuvers are displayed in a video. Conclusion We suggest applying this technique amid surgical scenarios involving ERM/ILM double peeling and double staining where an incidental ILM flap is found after washing out of the ILM-specific dye. Advantages over using conventional forcerps include the reduced number of entries into the posterior segment, lower risk of inadvertent retinal breaks, better safety profile, and easier-to-perform elongation of ILM flaps.
- Open Access
- 26 September 2023
- Published by Springer Nature in Research Square
Outcomes of Scleral Buckling Surgery in Rhegmatogenous Retinal Detachment: An Iranian Experience
Purpose: To evaluate the anatomical and visual outcomes of SB surgery in patients with rhegmatogenous retinal detachment (RRD) and investigate the impact of pre- and intraoperative factors on final surgical and functional success rates Methods: In this retrospective study, medical records from all patients with RRD for whom SB surgery was performed between March 2015 and October 2019 in Torfe Eye Hospital in Tehran, Iran, were included. Results: A total of 80 patients (54 males and 27 females) with a mean (±SD) age of 45 (±15; ranging from 19 to 80) underwent SB surgery. Primary and final retinal reattachment rates were 73.3% and 91.3%, respectively. The mean (±SD) pre- and postoperative best-corrected visual acuities were 1.04 (±0.8) and 0.73 (±0.58) LogMAR, respectively (P-valueConclusion: SB is an effective treatment option for rhegmatogenous retinal detachment. Our results clearly showed that the prognosis of patients with an intact macula is better than the others.
- 26 September 2023
- Published by Springer Nature in Research Square
Open AccessOutcomes of Scleral Buckling Surgery in Rhegmatogenous Retinal Detachment: An Iranian Experience
Purpose: To evaluate the anatomical and visual outcomes of SB surgery in patients with rhegmatogenous retinal detachment (RRD) and investigate the impact of pre- and intraoperative factors on final surgical and functional success rates Methods: In this retrospective study, medical records from all patients with RRD for whom SB surgery was performed between March 2015 and October 2019 in Torfe Eye Hospital in Tehran, Iran, were included. Results: A total of 80 patients (54 males and 27 females) with a mean (±SD) age of 45 (±15; ranging from 19 to 80) underwent SB surgery. Primary and final retinal reattachment rates were 73.3% and 91.3%, respectively. The mean (±SD) pre- and postoperative best-corrected visual acuities were 1.04 (±0.8) and 0.73 (±0.58) LogMAR, respectively (P-valueConclusion: SB is an effective treatment option for rhegmatogenous retinal detachment. Our results clearly showed that the prognosis of patients with an intact macula is better than the others.